Lipid-CSANs for Reversible Cell Surface Modification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for modifying cell surfaces lack specificity, stability, and reversibility, leading to unforeseen disruptions in cell membrane function and limited clinical applications, particularly in cancer therapy.
Innovation Solution
Development of lipid-chemically self-assembled nanorings (Lipid-CSANs) that can rapidly and reversibly integrate into cell membranes, allowing for stable and specific modification with targeting ligands, such as anti-EpCAM, enabling controlled cell-cell interactions and cancer cell targeting.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stability of the object's composition
If covalent modifications are used to modify cell surfaces, then stability of modification is improved, but reversibility deteriorates
Solution Approach 1:
The patent employs dynamic non-covalent interactions (host-guest chemistry between cyclodextrin and adamantane) instead of static covalent bonds, allowing the modification to be reversible while maintaining stability. The nanoring structures can assemble and disassemble on demand, providing both stability during function and reversibility when needed.
Solution Approach 2:
The patent changes the chemical interaction parameters from permanent covalent bonds to reversible non-covalent host-guest interactions. By using cyclodextrin-adamantane inclusion complexes, the system achieves high binding affinity (stable modification) while remaining responsive to environmental changes and removable (reversible).
2Stability of the object's composition
If chemical cross-linking methods are used to modify cell surfaces, then stability of modification is improved, but specificity deteriorates
Solution Approach 1:
The patent applies local quality by using site-specific enzymatic tagging (sortase A recognition sequence) to attach nanorings at precise locations on target proteins, rather than random cross-linking. This ensures modifications occur only at intended sites with high specificity while maintaining stability through the robust nanoring structure.
Solution Approach 2:
The patent introduces enzymatic recognition sequences as intermediaries between the target protein and the nanoring modification. The sortase A enzyme acts as a specific mediator that recognizes the tag sequence and catalyzes the attachment, ensuring high specificity while the resulting covalent bond provides stability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Lipid-CSANs demonstrate stable surface modification and selective binding to cancer cells, with rapid disassembly in the presence of trimethoprim, enhancing targeted cell lysis by activated T-cells, offering a promising tool for cancer therapy.
Implementation Method 1
lipid-chemically self-assembled nanorings (Lipid-CSANs) that can rapidly and reversibly integrate into cell membranes
Implementation Method 2
rapid disassembly in the presence of trimethoprim
Data Source
AI summary
Provided herein are compounds, conjugates and methods for making lipid-chemically self-assembled nanorings (Lipid-CSANs) and using them to treat diseases and modify cell surfaces.